508.907.6424 | npace@npace.org | Give Back | Blog
Loading Events
Early-bird registration by 07/23/20

Nashville, TN

August 27-30, 2020

Nashville, TN Conference
2-day Primary Care + 2-day Pharmacology
August 27-30, 2020
Omni Nashville Hotel
22 CONTACT HOURS | 12+ PHARMACOLOGY HOURS

 

Overview

Fulfill your professional development and specific licensure needs at these 2-day Primary Care and 2-day Pharmacotherapeutics continuing education conferences. Nashville TN Conference sessions emphasize the latest evidence and guideline-based clinical knowledge needed to prescribe and manage high priority primary care topics.

Primary Care (August 27-28) | 10 Contact Hours/(TBA Pharm Hours)
Pharmacology (August 29-30) | 12 Contact Hours/12 Pharm Hours

CONFERENCE REGISTRATION DEADLINES/FEES

Early registration – by July 23, 2020
General Attendee: $355 (one conference) I $680 (both conferences)
Senior (60+), Student/New Grad: $315 (one conference) I $635 (both conferences)

Standard Registration (all types except Military)  – after July 23, 2020
$420 (one conference) I $800 (both conferences)

Military – (anytime)
$295 (one conference) I $585 (both conferences)

All registrations are subject to a $50 non-refundable administration fee.

Keynote speaker

Susan S. VanBeuge, DNP, APRN, FNP-BC, FAANP

Speakers

Keynote Speaker: Susan S. VanBeuge, DNP, APRN, FNP-BC, FAANP
Dr. Susan VanBeuge is an Associate Professor in Residence at the University of Nevada, Las Vegas School of Nursing. She teaches in the Family Nurse Practitioner program and Doctor of Nursing Practice (DNP) programs at UNLV. She works in endocrinology and cardiometabolic practice seeing patients with a variety of endocrine and cardiovascular disorders. She works with patients managing diabetes using medication, insulin pumps, and real-time glucose monitoring and has presented on this topic at local and national conferences. Dr. VanBeuge has presented at the AANP conference since 2004 and is the current AANP Nevada State Representative and is an appointed member and current Vice-President of the Nevada State Board of Nursing.
Kathy Baldridge, DNP, APRN, FNP-BC, FAANP, FAIPM
Dr. Baldridge is currently the Director of Psychometric Analysis at APEA. She is a goal directed, results-oriented professional with a strong clinical background and education. Dr. Baldridge began her nursing career in 1993 and has been a Family Nurse practitioner since 2009. Subsequently, earning her Doctorate in Nursing Practice (DNP) from the University of Alabama in 2013.

In 2016, Dr. Baldridge received the Nurse Practitioner Excellence Award for the State of Louisiana and in 2017 became a Fellow of the American Association of Nurse Practitioners. She is the current president of the Louisiana Association of Nurse Practitioners. She is an accomplished author, speaker, and educator. Throughout, her career she has specialized in family practice, urgent care and neurology services. She was the Program Coordinator of Neurology Services in a long-term care facility for people with intellectual and developmental disabilities for over 8 years.

Dr. Baldridge remains in clinical practice in a primary and urgent care setting for the indigent population. She is actively involved in her community and church, providing health care education, outreach and screenings.
Stephen Brunton, MD, FAAFP
Dr. Brunton is Executive Vice President for Primary Care Education Consortium. He works in a group practice in suburban Los Angeles and holds the faculty rank of Associate Clinical Professor in the Department of Family Medicine at Touro University in Vallejo, California. He currently serves as the Editor-in-Chief for ‘Clinical Diabetes’, the ADA’s primary care journal, and as the Executive Director of the Primary Care Metabolic Group. Previously, he served as the Director of Education for the American Academy of Family Physicians. Dr. Brunton earned his medical degree at Monash University Medical School in Melbourne, Australia and completed his residency in family practice at Long Beach Memorial Medical Center in California. He is a board-certified family physician, with a certificate of added qualifications in geriatrics.
Phyllis Everett, MSN, RN, AOCN, AGN-BC, NP-C
Phyllis is a nurse practitioner certified in adult primary care, oncology and genetics. She has practiced at her NP owned and operated family practice in central Virginia, Huddleston Health and Wellness, since September 2017. She is also working with HCR-Manorcare, Heartland Hospice, performs in-home health assessments for Complex Care Solutions, and is a contractor for Admera Health.

She is also the owner of Sapient Health Services, PLLC a consulting service licensed in Virginia and North Carolina specializing in genetic testing services for hereditary cancer syndromes and pharmacogenomic testing. She received a diploma RN at Norfolk General Hospital School of Professional Nursing in 1979, a BS in Nursing with a Minor in Psychology at UNC-Greensboro in 1983 and her MS in Nursing Administration also at UNC-G in 1988. She earned two post-masters certificates at Duke, Nursing Informatics in 1997 and Adult Nurse Practitioner with a focus in Primary Care and Oncology in 2005.

Phyllis has published, and her original research has been presented in poster presentations at the national level. Phyllis was president of the Virginia Council of Nurse Practitioners(VCNP) from 2012-2014 and was awarded the Distinguished NP Award at the VCNP annual meeting in March 2016.
Alison O. Marshall, RN, MSN, FNP-C
Alison Marshall is a board certified, practicing Family Nurse Practitioner (FNP). She earned her Bachelor of Arts (B.A.) in Sociology with Honors from Boston College in 2000, and her Master’s in Nursing from Yale University in 2005. She is currently matriculating in the PhD program at Boston College, with expected graduation in 2023.

Alison’s nursing practice is based in Massachusetts. Alison has practiced at the South Boston Community Health Center since 2005. She is a full-time Clinical Instructor at the Boston College Connell School of Nursing. Alison is Faculty at The Sylvie Ratelle STD/HIV Prevention Center of New England, a Centers for Disease Control (CDC) funded national training organization for practicing providers. She engages in clinical research regarding sexually transmitted diseases (STDs) and lectures to practicing clinicians nationally and internationally about the identification, treatment, and prevention of STDs.
Sally K. Miller PhD, APRN, FNP-BC, AGACNP-BC, AGPCNP-BC, FAANP
Dr. Sally Miller has been practicing as a nurse practitioner for 25 years. She is board certified as a family NP, Adult/Geriatric, Acute NP, and recently as a Psych/Mental Health NP. Dr. Miller is an associate professor and Associate Dean for Graduate Affairs at the University of Nevada Las Vegas. She maintains an active clinical practice with ICarePsychiatry. Sally has published over 30 research and clinical articles with emphasis on issues related to adult health and illness as well as obesity. She has been an active conference presenter and author in the NP community since 1996.
Judith O'Haver, PhD, RN, CPNP-PC, FAANP, FAAN
Dr. Judith O'Haver obtained her BSN from Niagara University, her MS in nursing and NP certification from Arizona State University and her doctorate in nursing from University of Arizona. She is currently one of the Nurse Practitioners in the pediatric dermatology clinic at Phoenix Children’s Hospital and is a faculty associate at Arizona State University where she teaches in the DNP program. Dr. O'Haver's main research interest is the intervention research with underserved pediatric populations and their families to promote healthy lifestyle choices with a special focus on children and adolescents with dermatologic conditions and chronic disease.
John J. Russell, MD
Clinical Professor of Family and Community Medicine, Thomas Jefferson University, Sidney Kimmel School of Medicine, Philadelphia, PA

Chair, Department of Family Medicine, Program Director, Family Medicine Residency, Abington – Jefferson Health, Abington, PA
Kristine Ziemba, APRN, FNP-BC, CLS, AACC
Kristine is currently practicing at The New England Heart and Vascular Institute of Catholic Medical Center, Manchester NH where she serves as the Lead Advanced Practice Provider of General Cardiology, Associate Clinical Director of The Cholesterol Management Center and Clinical Director of The Women’s Cardiac Center. She has been employed at CMC since 1991, 17 years as a Cardiology Nurse Practitioner.

She received her Bachelor of Science Degree in Nursing from the University of New Hampshire (1991), graduating Magna Cum Laude. She completed her Master of Science Degree in Nursing from Rivier University (2002), graduating with High Distinction. She achieved certification as a Clinical Lipid Specialist (2011), currently a Diplomat of the Accreditation Council for Clinical Lipidology (ACCL). In 2018 she received the designation of Associate of The American College of Cardiology (AACC).

She currently holds memberships with The National Lipid Association (NLA), New Hampshire Nurse Practitioner Association (NHNPA), American College of Cardiology (ACC) and holds certification with The American Nurses Credentialing Center (ANCC). She was named as NH’s Nurse Practitioner of the Year (2010), thereafter receiving NH’s State Excellence Award from The American Academy of Nurse Practitioners (2011). She currently lives in Bedford, NH with her husband John.
Michael E. Zychowicz, DNP, FAAN, FAANP
Michael E Zychowicz, DNP is a Professor at Duke University School of Nursing where he is the Director of the MSN Program. Dr. Zychowicz has built a 20-year career in orthopedics as both a clinician, educator and scholar. He leads the only Orthopedic NP graduate educational program at Duke. Dr. Zychowicz is board certified as both an Adult NP and Orthopedic NP.

Agenda

Thursday, August 27, 2020

Registration

7:00 am - 8:00 am
Primary Care Conference Registration

Primary Care Conference

8:00 am - 9:00 am
Keynote: Call to Action
9:15 am - 10:15 am
PCEC1: IBS: Easing the Patient Burden

Family care clinicians are the first line of defense for patients suffering from IBS, a common disorder that causes substantial reduction in health-related quality of life. The diagnosis of IBS, whether it is IBS-D, IBS-M, or IBS-C, is generally made clinically, which is impacted by recent changes in the Rome criteria. Now recognized as both a brain-gut and a gut-brain disorder, the treatment of patients with IBS has evolved significantly in the past year. Understanding the patient burden of disease, particularly symptoms that are most troublesome, is helpful in individualizing therapy. The 2018 American College of Gastroenterology IBS guidelines lend clarity to treatments found effective, including soluble fiber and several medications, while finding little evidence to support the use of therapies such as a gluten-free diet, prebiotics/probiotics/synbiotics, and antispasmodics.

Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. Grant funded by Salix Pharmaceuticals, Inc.

 

10:25 am - 11:25 am
A1: Being an NP Preceptor
11:25 am - 12:00 pm
Sign in with Sponsor for Product Theater
12:00 pm - 1:00 pm
LP1: NON-CE Product Theater Lunch Session

This session is provided by a commercial interest. Contact Hours will not be awarded.

1:15 pm - 2:15 pm
PCEC2: Diabetes Management: Putting the Patient First

The management of patients with T2DM has undergone a seismic shift from a glucose- centric to a patient-centric focus with a primary goal of reducing cardiovascular risk. The shift to focus on cardiovascular risk stems not only from the fact that microvascular and macrovascular complications continue to be common in persons with type 2 diabetes mellitus, but also from evolving evidence clearly demonstrating cardiovascular risk reduction with some antidiabetic medications. To reduce the burden of disease and improve the journey of persons with type 2 diabetes, however, requires understanding the evidence base for these benefits and differences among the antidiabetic medications, and how treatment can be individualized to address the unmet needs of each patient.

Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. Grant funded by Lilly.

2:25 pm - 3:25 pm
B1: Inflammation and Oxidation: The Fire Behind the Smoke Screen
Friday, August 28, 2020

Primary Care Conference

7:00 am - 8:00 am
PCEC3: Stemming the Progression of Diabetic Kidney Disease: The Role of the Primary Care Clinician

The pharmacologic treatment of diabetic kidney disease (DKD) has typically involved treatment of associated risk factors such as blood glucose, blood pressure, and the use of medications that act on the renin-angiotensin-aldosterone system. Recently, a variety of glucose-lowering medications have been investigated to assess their potential for improved renal outcomes in patients with type 2 diabetes mellitus and with/without established DKD. Several of these medications have been shown to improve renal outcomes in patients with type 2 diabetes mellitus. This presentation seeks to provide insight into the results of these clinical trials and how the selected medications can be used to individualize therapy as recommended in updated guidelines issued by the American Diabetes Association and the American Association of Clinical Endocrinologists/ American College of Endocrinology.

Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit and AMA PRA Category 1 Credits. Sponsored by PCEC and PCMG Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc

8:15 am - 9:15 am
C1: The Unapproved Uses of Approved Medications: Exploring "off-label" Uses
9:15 am - 9:45 am
Exhibit Hall Grand Opening
9:45 am - 10:45 am
D1: Orthopedic Imaging: What to Order When
10:55 am - 11:55 am
E1: Potpourri of Rashes and Conditions - How to Differentiate
11:55 am - 12:30 pm
Sign in with Sponsor for Product Theater
12:30 pm - 1:30 pm
LP2: NON-CE Product Theater Lunch Session

This session is provided by a commercial interest. Contact Hours will not be awarded.

1:45 pm - 2:45 pm
F1: Monitoring for Chronic Dermatological Diseases and Treatments in the Primary Care Office
2:45 pm - 3:15 pm
Break and Exhibits
3:15 pm - 4:15 pm
G1: Orthopedics
Saturday, August 29, 2020

Registration

6:30 am - 8:00 am
Pharmacology Conference Registration

Pharmacology Conference

7:00 am - 8:00 am
PH-BR1: Expanding the Role of the NP in Managing Major Depressive Disorder: Challenge Accepted
This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.  This continuing nurse education activity is provided by Vindico Medical Education.
8:15 am - 9:45 am
PH1: Women's Health
10:15 am - 11:45 am
PH2: Men's Health
11:45 am - 12:15 pm
Sign in with Sponsor for Product Theater
12:15 pm - 1:15 pm
PH-LP1: NON-CE Product Theater Lunch Session

This session is provided by a commercial interest. Contact Hours will not be awarded.

1:30 pm - 2:45 pm
PH3: Hyperlipidemia
3:15 pm - 4:45 pm
PH4: Hypertension
Sunday, August 30, 2020

Pharmacology Conference

7:00 am - 8:00 am
PH-BR2: Influenza Treatment in the Primary Care Setting

By completing this session, participants will be able to apply new evidence into practice regarding the use of diagnostic testing, treatment and chemoprophylaxis for people with, or at risk for, influenza. Also, Incorporate the use of antiviral agents into practice based on their ability to reduce transmission, as well as treat people with influenza who are at normal or high risk for complications.

This activity is supported by an educational grant from Genentech, Inc. This continuing nurse education activity is provided by Vindico Medical Education.

8:15 am - 9:45 am
PH5: Pharmacogenomics
10:00 am - 11:30 am
PH6: Treatment of Common Hematological Disorders
1:15 pm - 2:45 pm
PH7: Pharmacokinetics and Pharmacodynamics: Special Considerations in the Geriatric Patient
3:00 pm - 4:30 pm
PH8: The Pharmacodynamics of Antimicrobial Therapy

Fee

BOTH CONFERENCES: 2-DAY PRIMARY CARE + 2-DAY PHARMACOLOGY

General Attendee $800.00
Discounted Price
If Registered By

$680.00

Thursday, July 23, 2020

Senior (60+) /Student/New Grad $800.00
Discounted Price
If Registered By

$635.00

Thursday, July 23, 2020

Military $585.00

PRIMARY CARE ONLY (2 DAYS)

General Attendee $420.00
Discounted Price
If Registered By

$355.00

Thursday, July 23, 2020

Senior (60+)/Student/New Grad $420.00
Discounted Price
If Registered By

$315.00

Thursday, July 23, 2020

Military $295.00

PHARMACOLOGY ONLY (2 DAYS)

General Attendee $420.00
Discounted Price
If Registered By

$355.00

Thursday, July 23, 2020

Senior (60+)/Student/New Grad $420.00
Discounted Price
If Registered By

$315.00

Thursday, July 23, 2020

Miltary $295.00
All registrations are subject to a $50 non-refundable administration fee.

REFUND AND CANCELLATION POLICY

FEES:

All registrations must be paid in full by credit card (Visa, MasterCard, American Express and Discover) at the time of registration. NPACE no longer accepts payment by check. 4th for Free, Letter of Credit and complimentary registrations all require a $50 non-refundable administration fee upon registration.

If using Letter of Credit, 4th for free, or complimentary registration, please contact NPACE 508-907-6424 x1 for registration information.

CANCELLATION BY REGISTRANT:

Written notice of cancellation must be received by email or letter. A refund, excluding the $50 non-refundable administrative fee, will be issued when cancellation is received no later than one month prior to the conference start date. Refunds are processed based on the original form of payment.

A letter of credit, excluding the $50 non-refundable administrative fee, will be issued when cancellation is received between 30 and 8 days of the conference start date. This is valid for 12 months from issuance and may be used for towards any NPACE conference.

No refunds will be issued for cancellations received within 7 days of the conference start date.

CANCELLATION OF EVENT:

In the very unlikely event that NPACE cancels or postpones a conference due to circumstances beyond its control, NPACE’s liability shall be limited to refund of paid registration fees.

HOTEL

HOTEL INFORMATION

Omni Nashville
250 5th Avenue South
Nashville, TN 37203
Image 1
Cut Off Date: August 4, 2020 (5:00pm local time)
Discounted Rate: $246.00 (plus local/state taxes)
Resort Fee: Waived
Online Reservations: CLICK HERE FOR RESERVATIONS
Based on availability; Group rates can apply 3 days before and after the conference dates

Other Information

Complimentary WIFI in guestrooms
Complimentary fitness center access
$3.00 Discount on published valet parking rates

NPACE Room Block Note

NPACE strongly advises that you do not make travel reservations until you have a confirmed conference registration. NPACE conferences frequently sell out prior to early registration date.

Hotel Rates are based on room block availability and can’t be guaranteed if room block sells out before cut off dates. Space and room types are limited, so please make your reservations early! Hotel cancellation policies vary, check with hotel for cancellation policy if you need to cancel your reservation. Only reservations made through the group block are eligible for additional amenities and discounts.

Omni Nashville Entrance Nashville Hotel
Nashville Hotel Lobby Lobby Lounge Nashville Hotel
Nashville King Room Nashville Guest Room
Mokara Spa Nashville Nashville Fitness Room
 Omni Nashville Hotel Rooftop Pool  Image result for omni nashville

Abstract Submission

NPACE is currently accepting poster abstracts for our 2020 conference in Nashville, TN. Research should be focused on health policy, innovation, evidence based clinical practice, scientific research, or collaboration and interdisciplinary practice. Sub-topic ideas should include primary care, mental health, pediatrics, geriatrics, or palliative- end of life care. Submission is open to students and faculty from MSN, DNP, and PhD programs.

Simply complete the Abstract Submission Form below to submit your abstract for review.

KEY DATES:

June 15, 2020 Online submission of abstracts close
June 22, 2020 Email notification sent to all submissions
July 1, 2020 Deadline to return completed Presenter Agreement
July 10, 2020 Deadline to register for conference

GUIDELINES FOR POSTER ABSTRACT

  1. Full name of submitting/corresponding author and all co-authors
  2. Abstract text:
    1. Use Times New Roman, 12 Font, 1-inch margins
    2. Limit to 300 words excluding title, authors info (affiliations) and references
  3. Highlight the main points:
    1. Introduction: Info statement with purpose of the presentation
    2. Methods: Brief description of the research-background
    3. Discussion: Summary of the unpublished data or other relevant info
    4. Conclusion: Summarize in 1 or 2 sentences the primary outcomes of the study, including their potential significance
  4. Funding sources: Funding sources (organizations, institutions, agencies) for the research included in the abstract should be listed.
  5. Must not contain any commercial bias

SUBMISSION REQUIREMENTS

  • Resume(s) for author(s)
  • Short bio statements for all poster authors
  • One measurable learning outcome.
  • 50-word presentation summary that will be used for conference publication
  • Entire poster must fit onto a 3-foot x 4-foot board
  • Co-authors submitted with the accepted abstracts will be included in the conference materials.
  • Decisions on abstract acceptance are final.

ATTENDANCE REQUIRED

Accepted abstracts must have a presenter in attendance during conference session breaks on August 27, 2020 to present their poster(s).

It is not mandatory that the first author be pre-registered and present; the presenter may be any of the contributing authors or a colleague.

CONFERENCE REGISTRATION FEE

Author associated with an abstract must register for the conference and are responsible for all travel expenses (airfare, hotel, etc.) associated with presenting at the meeting. The conference registration is separate from the abstract submission. Abstracts will be removed from the conference if author(s) are not registered for the conference by May 22, 2020. If a presenter(s) withdraws from the conference the poster submission will be removed.

Note our Faculty Program: We recognize the important role of academic faculty in preparing the next generation of NP leaders, and as a show of support, we offer one free conference registration per 24-month period to full-time faculty of NP academic programs. A limited number of seats are put aside at each conference for faculty taking advantage of this NPACE Perk.

ABSTRACT REVIEW

All abstracts will be reviewed and selected based on criteria requirements by an NPACE nurse planner. This will ensure adherence to ANCC Commission on Accreditation CE provider guidelines.

AUTHORS’ AGREEMENT

Upon acceptance of an abstract, presenters will receive a presenter agreement with dates and guidelines. This agreement will need to be signed and returned to NPACE within one week of receipt of email notification of poster acceptance. Failure to return agreement will result in removal of the abstract from the presentation.

ELECTRONIC EPOSTERS

Upon acceptance of an abstract, presenters will receive information pertaining to the NPACE ePoster learning toolbox. These ePosters are web-based allowing presenters to quickly and easily build a virtual ePoster using stacks of interactive blocks containing vital information including text, graphics, links to video and other websites. Presenter will be also asked to provide 5 multiple choice questions/answers for NPACE to create a google quiz that will be incorporated into your ePoster. This will allow learners to earn contacts hours for viewing the ePoster and completing the online quiz.  By utilizing this ePoster system, NPACE will house your poster in its online library for other medical professions to view in the future.

Registration

Join NPACE Community

Keep up with the latest news and updates.

COVID-19 LATEST INFORMATION

X myStickymenu